Smith Cynthia insider trades
Smith Cynthia has filed 28 Form 4s with the SEC that we hold, for Agios Pharmaceuticals, INC. (AGIO) (Director), Spero Therapeutics, Inc. (SPRO) (Director), Akebia Therapeutics, Inc. (AKBA) (Director) and Protara Therapeutics, Inc. (TARA) (Director), among 6 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-08-18 and the latest 2026-06-25.
Agios Pharmaceuticals, INC. (AGIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Spero Therapeutics, Inc. (SPRO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Akebia Therapeutics, Inc. (AKBA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Protara Therapeutics, Inc. (TARA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Tvardi Therapeutics, Inc. (TVRD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
DRNA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1609480) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms